Trends of resistance of Gram-negative bacteria in the ICU during a 3-year period

Documenti analoghi

• Efficacy and safety of colistin in the treatment of infections in the ICU caused by multidrug-resistant Gram-negative organisms
  di: Pavleas, J, et al.
  Pubblicazione: (2006)
• The use of recombinant factor VIIa as a haemostatic agent in ICU patients
  di: Vernikos, P, et al.
  Pubblicazione: (2004)
• Systemic rheumatic diseases in the ICU
  di: Vernikos, P, et al.
  Pubblicazione: (2009)
• Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria
  di: Watkins, Richard R., et al.
  Pubblicazione: (2019)
• Factors associated with survival of ICU patients with pneumonia caused by multidrug-resistant Gram-negative bacteria
  di: Georgiadou, M, et al.
  Pubblicazione: (2015)